The venous system returns deoxygenated blood to the heart:

Deep Veins:

• Located within muscle compartments
• Accompanied by arteries
• High-pressure system
• Most DVTs occur in deep veins

Superficial Veins:

• Located in subcutaneous tissue
• Not accompanied by arteries
• Lower pressure system
• Thrombophlebitis often affects these

Perforator Veins:

• Connect deep and superficial systems
• Have one-way valves
• Important for DVT progression

The balance between clot formation and breakdown involves:

Clot Formation (Pro-coagulant):

• Tissue factor pathway (extrinsic)
• Contact activation pathway (intrinsic)
• Common pathway leads to fibrin formation

Clot Breakdown (Anti-coagulant):

• Antithrombin III inhibits thrombin
• Protein C pathway inactivates Factors V and VIII
• Tissue plasminogen activator (tPA) activates plasmin

When This Balance Tips Toward Clotting:

• Hypercoagulable states
• Stasis allows clotting factors to accumulate
• Endothelial injury exposes tissue factor

When clots break loose (embolize):

1. Travel through venous system to right heart
2. Enter pulmonary arteries
3. Block pulmonary blood flow
4. Impair gas exchange
5. Can cause right heart strain or death

1. Deep Vein Thrombosis (DVT)

Common Sites:

• Lower extremities (90% of DVTs)
• Pelvic veins
• Sometimes upper extremities (less common)

Characteristics:

• Usually involves deep veins
• Risk of embolization
• Can cause post-thrombotic syndrome

2. Superficial Thrombophlebitis

Characteristics:

• Affects superficial veins
• Usually less serious
• Can be painful
• May extend to deep veins (rare)

3. Pulmonary Embolism (PE)

Types:

• Massive PE: Hemodynamic instability
• Submassive PE: Right heart strain, stable blood pressure
• Low-risk PE: Stable, no right heart strain

4. Other Locations

• Cerebral venous thrombosis: Brain veins
• Mesenteric thrombosis: Intestinal veins
• Portal vein thrombosis: Liver portal vein
• Renal vein thrombosis: Kidney veins

Primary (Inherited) Thrombophilias:

• Factor V Leiden mutation
• Prothrombin G20210A mutation
• Protein C deficiency
• Protein S deficiency
• Antithrombin III deficiency

Secondary (Acquired):

• Cancer-associated
• Surgery/trauma
• Immobility
• Antiphospholipid syndrome
• Heparin-induced thrombocytopenia
• Inflammatory conditions

1. Inherited Hypercoagulable States

Factor V Leiden:

• Most common inherited thrombophilia
• Resistance to activated protein C (APC resistance)
• 5-10% of population carriers
• 10-40% of thrombosis patients

Prothrombin G20210A:

• Elevated prothrombin levels
• Second most common inherited thrombophilia

Protein C Deficiency:

• Rare but significant
• Causes severe neonatal thrombosis if homozygous
• Heterozygotes have 10x risk

Protein S Deficiency:

• Similar presentation to Protein C
• Free Protein S measurement important

Antithrombin III Deficiency:

• Most severe inherited thrombophilia
• 50x increased risk in homozygotes
• Affects 0.2% of population

2. Acquired Hypercoagulable States

Cancer:

• Tumor cells release pro-coagulant factors
• Treatment increases risk further
• "Trousseau's syndrome" - migratory thrombophlebitis

Antiphospholipid Syndrome:

• Autoimmune condition
• Lupus anticoagulant, anticardiolipin, anti-B2-glycoprotein I
• Arterial and venous thrombosis
• Pregnancy complications

Heparin-Induced Thrombocytopenia (HIT):

• Paradoxical - heparin causes both low platelets AND thrombosis
• 4-10 days after heparin exposure
• Requires immediate recognition

3. Situational Factors

Surgery:

• Especially orthopedic, pelvic, abdominal
• Up to 40% risk without prophylaxis
• Risk highest 2-10 days post-op

Trauma:

• Major trauma increases risk significantly
• Lower extremity fractures particularly risky

Immobility:

• Bed rest
• Long travel (>4-6 hours)
• Hospitalization
• Nursing home residents

• Varicose veins
• Inflammatory bowel disease
• Nephrotic syndrome
• Myeloproliferative disorders
• Heart failure
• COPD

• High rates of diabetes and metabolic syndrome: Increases baseline risk
• Climate: Dehydration in hot months may concentrate blood
• Travel patterns: Many international travelers through Dubai
• Genetic factors: Consanguinity may increase inherited conditions
• Healthcare utilization: May delay seeking care

Classic Presentation (May-Day Signs):

• Swelling (edema) - usually one leg
• Pain - cramp-like or aching
• Warmth - affected area warmer
• Redness (erythema) - over affected vein
• Dilated superficial veins - collateral circulation

"Silent" DVT:

• Up to 50% of DVTs are asymptomatic
• Found incidentally on imaging
• Still carry embolization risk

Classic Triad:

• Dyspnea (shortness of breath) - sudden onset
• Pleuritic chest pain - worse with breathing
• Hemoptysis (coughing blood) - less common

Other Symptoms:

• Tachypnea (rapid breathing)
• Tachycardia (rapid heart rate)
• Syncope (fainting)
• Anxiety/feeling of dread
• Lightheadedness
• Cyanosis (blue lips/fingernails)

Call Emergency If:

• Sudden difficulty breathing
• Chest pain that worsens with breathing
• Coughing up blood
• Fainting or loss of consciousness
• Rapid heart rate with shortness of breath
• Confusion
• Severe lightheadedness

• Recent surgery or hospitalization
• Recent trauma
• Prolonged immobility
• New onset estrogen use
• Recent diagnosis of cancer

• Heart disease (especially atrial fibrillation)
• Stroke (can be complication)
• Kidney disease (nephrotic syndrome)
• Inflammatory conditions (IBD, lupus)
• Infections (especially COVID-19)

Acute:

• Pulmonary embolism (can be fatal)
• Phlegmasia cerulea dolens (massive DVT with limb threat)

Chronic:

• Post-thrombotic syndrome (PTS)
• Chronic thromboembolic pulmonary hypertension (CTEPH)
• Recurrent thrombosis

Step 1: Comprehensive History

Key Questions:

1. Have you had leg swelling or pain? Which leg?
2. When did symptoms start?
3. Have you been recently ill, hospitalized, or had surgery?
4. Have you traveled recently?
5. Are you taking any medications (especially hormones)?
6. Have you ever had a blood clot before?
7. Does anyone in your family have blood clotting disorders?
8. Do you have any known medical conditions?

Step 2: Physical Examination

DVT Examination:

• Measure both legs for swelling asymmetry
• Palpate for tenderness along vein
• Check for warmth and redness
• Assess collateral vein dilation

PE Examination:

• Check oxygen saturation
• Listen to lungs
• Check for heart murmurs or gallop
• Assess for jugular venous distension

D-dimer:

• Blood test
• Measures fibrin breakdown products
• Negative: Effectively rules out DVT/PE (high negative predictive value)
• Positive: Non-specific - requires imaging

Venous Doppler Ultrasound:

• First-line for DVT
• Non-invasive
• Shows clot in vein
• Compression ultrasound assesses clot

CT Pulmonary Angiogram (CTPA):

• Gold standard for PE
• Shows filling defects in pulmonary arteries
• Also shows lung infarction if present

Ventilation-Perfusion (V/Q) Scan:

• Alternative if CT contraindicated
• Shows perfusion defects

If indicated (recurrent VTE, unusual site, family history):

• Factor V Leiden
• Prothrombin G20210A
• Protein C activity
• Free Protein S antigen
• Antithrombin activity
• Antiphospholipid antibodies
• Homocysteine

Direct Oral Anticoagulants (DOACs):

• Apixaban: 10mg BID x7 days, then 5mg BID
• Rivaroxaban: 15mg BID x21 days, then 20mg daily
• Dabigatran: 150mg BID (requires 5-10 day parenteral first)
• Edoxaban: 60mg daily

Vitamin K Antagonists:

• Warfarin: Started with heparin overlap
• Requires regular INR monitoring (target 2.0-3.0)
• Many drug and food interactions

Parenteral Anticoagulants:

• Unfractionated heparin: IV, requires monitoring aPTT
• Low molecular weight heparin (enoxaparin): SubQ, once or twice daily
• Fondaparinux: SubQ, once daily

Indications:

• Massive PE with hemodynamic instability
• Limb-threatening DVT (phlegmasia cerulea dolens)
• Large iliofemoral DVT

Agents:

• Tissue plasminogen activator (tPA)
• Reteplase
• Tenecteplase

Risks: Major bleeding, including intracranial hemorrhage

Indications:

• Contraindication to anticoagulation
• Recurrent PE despite anticoagulation
• Massive PE with residual DVT

Types:

• Permanent
• Retrievable (temporary)

Compression Stockings:

• Graduated compression (20-30 mmHg typically)
• Reduces post-thrombotic syndrome risk
• Must be properly fitted

At Healers Clinic, we support conventional thrombosis treatment with integrative approaches.

Constitutional homeopathy addresses underlying susceptibility:

Remedies Considered:

• Arnica montana: Bruising, trauma, fear of being touched
• Bellis perennis: Deep tissue, post-surgical
• Bothrops: Hemorrhagic tendencies, clotting issues
• Lachesis: Hot, jealous, left-sided
• Naja: Heart/circulation remedies
• Secale cornutum: Circulatory disturbances

Pitta-Pacifying Approach: In Ayurveda, thrombosis relates to Pitta dosha (governs blood and circulation) and may involve:

• Dietary modifications to reduce Pitta
• Cooling herbs and formulations
• Lifestyle recommendations
• Gentle circulation-supporting practices

Anti-inflammatory Approach:

• Omega-3 fatty acids (anti-inflammatory)
• Antioxidant-rich foods
• Adequate hydration
• Avoid pro-inflammatory foods
• Maintain healthy weight

Vascular Health Nutrients:

• Vitamin C (supports vessel integrity)
• B-complex vitamins
• Magnesium (supports circulation)
• Glutathione (antioxidant support)

Safety Precautions:

• Avoid contact sports/injury risk
• Use soft toothbrush
• Avoid sharp objects
• Wear medical alert bracelet if on warfarin
• Regular monitoring as prescribed

1. Stay Active: Regular movement, walking
2. Maintain Healthy Weight: Reduces stasis
3. Stay Hydrated: Prevents blood concentration
4. Avoid Smoking: Reduces endothelial damage
5. Manage Chronic Conditions: Diabetes, blood pressure

• Move legs regularly
• Ankle circles, calf raises
• Walk every 1-2 hours
• Stay hydrated
• Consider compression stockings
• Avoid tight clothing

During High-Risk Periods:

• Prophylactic anticoagulation after surgery
• Early mobilization
• Compression devices
• Adequate hydration

• Maintain anticoagulation as prescribed
• Regular follow-up
• Watch for recurrence
• Manage risk factors

• Risk assessment for high-risk situations
• Prophylaxis during surgery/pregnancy
• Avoid estrogen if high risk
• Family screening may be indicated

DVT:

• Most resolve with 3-6 months anticoagulation
• Risk of recurrence: 5-10% after stopping
• Post-thrombotic syndrome: 20-50%

PE:

• Mortality <5% with appropriate treatment
• Most recover fully
• Risk of chronic complications: CTEPH 1-4%

• Underlying cause (reversible vs. permanent)
• Extent and location of clot
• Promptness of treatment
• Adherence to anticoagulation
• Underlying health conditions

Q: How do I know if I have a blood clot?

A: See a doctor for evaluation. Common symptoms of DVT include leg swelling (usually one leg), leg pain or cramping, warmth, and redness. PE symptoms include sudden shortness of breath, chest pain worse with breathing, and coughing blood. Many DVTs have no symptoms.

Q: Can I prevent blood clots?

A: Yes, to some degree. Stay active, stay hydrated, avoid long periods of sitting, maintain healthy weight, don't smoke, and move your legs during travel. If you have risk factors, talk to your doctor about prophylaxis.

Q: Are blood clots hereditary?

A: Some are - Factor V Leiden, prothrombin gene mutation, and protein C/S/antithrombin deficiencies are inherited. However, most blood clots occur from a combination of factors, not just genetics.

Q: How long do I need blood thinners?

A: This varies by individual. After a first provoked DVT/PE, typically 3-6 months. For unprovoked or recurrent events, longer treatment may be needed. Some patients require indefinite anticoagulation.

Q: Can I exercise with a blood clot?

A: After the acute phase and while on anticoagulation, gentle activity is encouraged. Avoid contact sports or activities with injury risk while on blood thinners. Follow your doctor's guidance.

Q: How does homeopathy help with thrombosis?

A: Homeopathy doesn't treat the acute clot but can address constitutional susceptibility and support overall health. Constitutional treatment may help reduce recurrence tendency.

Q: What role does Ayurveda play?

A: Ayurveda focuses on balancing Pitta dosha (governs blood and circulation), improving digestion and nutrition, and supporting healthy lifestyle to reduce thrombotic risk.

Q: What nutritional support helps?

A: Anti-inflammatory foods, omega-3s, adequate hydration, and maintaining healthy weight all support vascular health. Avoid excessive vitamin K if on warfarin.

Healers Clinic Dubai 📞 +971 56 274 1787 🌐 https://healers.clinic/booking/

This content is for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider for diagnosis and treatment. Blood clots are serious medical conditions requiring immediate conventional medical attention. At Healers Clinic, we combine ancient wisdom with modern science to help you heal from the core.